Clinical Trials in Blida, Algeria
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Efficacy of Neoadjuvant Subcutaneous Trastuzumab-Pertuzumab in Algerian Women With Locally Advanced HER2 Positive Breast Cancer
Non Metastatic HER2 Positive Breast Cancer
Blida 1 University70 enrolled1 locationNCT07166185
Recruiting
Phase 2
Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.
Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
International Cancer Research Group, United Arab Emirates80 enrolled7 locationsNCT05190094